Direxion Daily S&P Biotech Bull 3X Shares (LABU)
50.73
+2.69
(+5.60%)
USD |
NYSEARCA |
May 16, 16:00
48.48
-2.25
(-4.44%)
After-Hours: 20:00
Key Stats
Customize
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.93% | 0.11% | 561.17M | 2.595M |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.22% | 179.0% | -315.05M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Miscellaneous |
| Broad Category | Equity |
| Global Peer Group | Alternative Equity Leveraged |
| Peer Group | Equity Leverage Funds |
| Global Macro | Alternative Equity |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Leverage Funds |
| Fund Owner Firm Name | Direxion |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 17, 2025.
Asset Allocation
As of April 30, 2025.
| Type | % Net |
|---|---|
| Cash | 5.43% |
| Stock | 63.99% |
| Bond | 38.34% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -7.76% |
Basic Info
| Investment Strategy | |
| The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Miscellaneous |
| Broad Category | Equity |
| Global Peer Group | Alternative Equity Leveraged |
| Peer Group | Equity Leverage Funds |
| Global Macro | Alternative Equity |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Leverage Funds |
| Fund Owner Firm Name | Direxion |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |